Meduloblastoma: Resultados de Tratamento de 17 Pacientes
DOI:
https://doi.org/10.32635/2176-9745.RBC.1986v32n2.3246Keywords:
Medulloblastoma, Surgery, RadiotherapyAbstract
Results of treatment for meduloblastoma were evaluated in 17 patients at Centro de Oncologia Campinas (Sao Paulo, Brazil). Follow-up periods ranged from 5 to 88 months. All patients underwent surgery and radiotherapy. Recurrences ocurred in two patients (22.5%). Overall survival rate at 1 year was 94%and it was 85% at 5 years. Neurological sequelae were considered to be minimal and inexpressive.
Downloads
References
Anderson WAD, Kissane JM. Pathology. Guanabara Koogan, 1982: 1744-1745.
Devita JR VT, HelIman S, Rosemberg SA. Cancer Principles and Pratice of OncoIogy. Lippincott. 1980: 1190-1229.
Bloom HJG, Lemerie J, Neidhardt MK Netherlands PAV. Cancer in Children (Clinical Manegement): Spreinger-Verlag. 1975: 105-108. DOI: https://doi.org/10.1007/978-1-4899-2776-7
Freeman AI. Introduction. Cancer, 1985; 56: 1743-1744. DOI: https://doi.org/10.1002/1097-0142(19851001)56:7+<1743::AID-CNCR2820561302>3.0.CO;2-K
Levin AV, Edwards MS, Wara WM, Fulteon D, Berger G, Wilson CB. Improvements in survival produced by sequencial therapies in the treatment of recurrent medulloblastoma. Cancer. 1983; 51: 1364-1370. DOI: https://doi.org/10.1002/1097-0142(19830415)51:8<1364::AID-CNCR2820510808>3.0.CO;2-5
Fletcher GH. Textbook of Radiotherapy. Lea & Febiger. 1980: 470.
Chin HS, Maruyama Y. Age at treatment and Iong-term performance results in medulloblastoma. Cancer. 1984; 53: 1952-1958. DOI: https://doi.org/10.1002/1097-0142(19840501)53:9<1952::AID-CNCR2820530925>3.0.CO;2-X
Latchaw JP, Hahn JF, Moylan DS, Humphries R, Mealey J. Medulloblastoma: period of risk reviewed. Cancer. 1985; 55: 186-189. DOI: https://doi.org/10.1002/1097-0142(19850101)55:1<186::AID-CNCR2820550129>3.0.CO;2-X
Deutsch M, Laurent JP, Cohen ME. Myelography for staging medulloblastoma. Cancer. 1985; 56: 1763-1766. DOI: https://doi.org/10.1002/1097-0142(19851001)56:7+<1763::AID-CNCR2820561306>3.0.CO;2-6
Laurent JP, Chnag CH, Cohen ME. A cIassification system for primitive neuroectodermal tumor (Medullobiastoma) of the posterior fossa. Cancer. 1985; 56: 1807-1809. DOI: https://doi.org/10.1002/1097-0142(19851001)56:7+<1807::AID-CNCR2820561317>3.0.CO;2-U
Kun LE D'Souza B, Teft M. The value fo surveillance testing in childhood brain tumor. Cancer. 1985; 56: 1818-1823. DOI: https://doi.org/10.1002/1097-0142(19851001)56:7+<1818::AID-CNCR2820561320>3.0.CO;2-9
Kolpelson G, Linggod RM, KIeinman GM. Medulloblastoma in adults: improved survival with supervoltage radiation therapy. Cancer. 1982; 49: 1334-1337. DOI: https://doi.org/10.1002/1097-0142(19820401)49:7<1334::AID-CNCR2820490704>3.0.CO;2-C
Jereb B, Krishnaswami S, Allen JC. Radiation for medulloblastoma adjusted to prevent recurrence to the cribriform plate region. Cancer. 1984; 54: 602-604. DOI: https://doi.org/10.1002/1097-0142(19840801)54:3<602::AID-CNCR2820540336>3.0.CO;2-Y
Farwell JR, Dohrmann.GJ, Flannery JT. Medulloblastoma in childhood: an epidemiological study. J Neurosurg. 1984; 61: 655-663. DOI: https://doi.org/10.3171/jns.1984.61.4.0657
